Recent Updates
Recently added Catalysts
BAKER BROS. ADVISORS
Track BAKER BROS. ADVISORS's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Aug 27, 2026
Showing 6 Stocks Out Of 78. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 REPL | Replimune Group, Inc. | 11.05 M | 122.27 M | 0.6 | |
 ABCL | AbCellera Biologics Inc. | 33.01 M | 259.14 M | 1.3 | |
 CRNX | Crinetics Pharmaceuticals, Inc. | 2.35 M | 87.99 M | 0.4 | |
 XNCR | Xencor, Inc. | 1.10 M | 17.74 M | 0.1 | |
 ABSI | Absci Corporation | 2.13 M | 24.74 M | 0.1 | |
 NRIX | Nurix Therapeutics, Inc. | 4.66 M | 113.02 M | 0.6 |
Market Value
$ 19.77 B
Holdings
78
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
14.58 %